GLP-1 pricing in continental Europe is fragmented in a way the UK and US markets are not. Every country has its own licensing, its own pharmacy pricing, and its own reimbursement rules — and the single most consequential rule is one most patients never check: many national systems reimburse GLP-1s for type 2 diabetes but not for weight management. This guide sets out what treatment actually costs across European markets, which providers publish real numbers, and how reimbursement changes everything.

Quick Takeaway:

• Indicative European ranges run about €250–€350/month for semaglutide and €200–€300/month for liraglutide
• DoktorABC publishes Wegovy at around €370/month at maximum dose, and a liraglutide generic at around €130/month
• Dokteronline publishes Mounjaro at €180–€280/month in the Dutch market without reimbursement
• Wellis publishes semaglutide from €149/month and Mounjaro from €259/month
• Reimbursement usually depends on indication: diabetes is frequently covered, weight management frequently is not

Looking for a Better Alternative?

We benchmark every provider against the highest-rated service we track. CoreAge Rx is our top-rated favorite for GLP-1 weight loss therapy overall, combining competitive pricing with exceptional customer service, faster medication delivery, and more comprehensive support resources.

Why we recommend CoreAge Rx:

• Lower monthly costs than most competitors ($179–$399 range)
• Faster prescription approval (typically 12–24 hours)
• More extensive provider support included at no extra charge
• Better medication availability during shortages
• Higher patient satisfaction scores (4.7/5)

CoreAge Rx serves patients in the United States. European readers should compare the providers set out below.

New Patient Special: Save up to $200 on your first three months. Rated 4.7/5 stars by verified customers. Available to patients in the United States.

The European Market at a Glance

Mobi Doctor publishes the most useful cross-market reference points available: about €250 to €350 per month for semaglutide (Wegovy) and about €200 to €300 per month for liraglutide (Saxenda), noting that prices vary between different pharmacies.

The Reimbursement Question

This is the part that matters most, and it is systematically underexplained.

Across most European statutory health systems, GLP-1 medicines are reimbursed when prescribed for type 2 diabetes and not reimbursed when prescribed for weight management alone. Dokteronline states this directly for the Dutch market: Mounjaro costs €180–€280 per month without reimbursement, and for type 2 diabetes reimbursement may be available through your insurer.

The practical consequence is stark. Two patients receiving the identical medicine can pay wildly different amounts depending on which indication their prescription carries — and that indication is a clinical determination, not something to be negotiated.

What to do: if you have type 2 diabetes or prediabetes, speak to your own doctor before going through a private weight loss service. The reimbursed route is dramatically cheaper where you qualify for it clinically.

Three Models, Three Cost Structures

European providers work in ways that are not directly comparable, so understanding the model matters before comparing prices.

1. Prescribe-only. Mobi Doctor charges €43 for a video consultation and issues a prescription; you buy the medication at a pharmacy. Your total is €43 plus pharmacy pricing — and because pharmacy pricing varies meaningfully within countries, you can shop your prescription. Mobi Doctor also states you receive a full refund if the doctor cannot treat you online.

2. Prescribe and dispense. DoktorABC and Dokteronline handle both, delivering medication to you. Simpler, but you accept their pricing.

3. Subscription programme. Wellis bundles medication with a personalised treatment plan and free delivery into a monthly subscription — closer to the US model than most European services.

Pro Tip: For European patients, the prescribe-only model is frequently the cheapest path, because it lets you separate the cost of clinical assessment from the cost of the drug and shop the latter. It requires more effort and does not help you during supply shortages.

The Cheap Option Most Patients Miss

DoktorABC identifies Nevolat, a liraglutide generic, at around €130 per month as currently the cheapest weight loss injection in the German market. Liraglutide is a daily injection producing more modest average weight loss than weekly semaglutide or tirzepatide — but at roughly a third the cost of Wegovy at maximum dose.

Ten percent body weight loss is the threshold at which most obesity-related comorbidities begin to improve meaningfully. A treatment you can sustain for two years at €130 a month does more for your health than one you abandon after three months at €370. Our alternative treatments guide covers where the older agents fit.

Country-Specific Notes

United Kingdom. A separate and better-documented market. NICE has recommended tirzepatide for weight management within defined criteria, with phased NHS rollout, and NHS treatment costs the standard prescription charge or nothing if exempt. Private Mounjaro runs roughly £129–£339 across providers. See our UK cost guide and best UK providers ranking.

Ireland. Served by LloydsPharmacy Online Doctor through a dedicated Irish service — one of relatively few regulated routes. Irish reimbursement schemes differ from the UK system; check your national arrangements.

Netherlands and Belgium. Dokteronline and Wellis both operate here, with Mounjaro published at €180–€280 and semaglutide from €149 respectively.

Germany and Austria. DoktorABC is the largest established route, with the liraglutide generic at around €130 as the budget option.

Nordics. Embla operates in Denmark and the UK, uniquely selling coaching standalone at £110/month. Yazen operates in Sweden and has presented outcome data on more than 30,000 patients at the European Congress on Obesity.

How to Reduce What You Pay in Europe

1. Check your indication. If you have type 2 diabetes, the reimbursed route is far cheaper.
2. Ask your own doctor first. National weight management pathways exist in several systems and cost a fraction of private treatment.
3. Consider prescribe-only, then shop the pharmacy. Pharmacy pricing varies within countries.
4. Consider liraglutide if the weekly agents are unaffordable — around €130/month versus around €370.
5. Price your maintenance dose, not the starter dose.
6. Check whether coaching is bundled and whether you will use it.

Frequently Asked Questions

How much does GLP-1 treatment cost in Europe?

Indicative ranges published by Mobi Doctor are about €250 to €350 per month for semaglutide (Wegovy) and about €200 to €300 per month for liraglutide (Saxenda), with prices varying between pharmacies. Published provider pricing runs from around €130/month for a liraglutide generic to around €370/month for Wegovy at maximum dose.

Is GLP-1 treatment reimbursed in Europe?

It depends on the indication and the country. Most statutory systems reimburse GLP-1s prescribed for type 2 diabetes but not for weight management alone. Dokteronline states this directly for the Dutch market. Check your national and insurer-specific arrangements.

What is the cheapest GLP-1 option in Europe?

DoktorABC identifies a liraglutide generic at around €130 per month as currently the cheapest injectable option in the German market. Liraglutide is a daily injection producing more modest average weight loss than weekly semaglutide or tirzepatide.

Do I need a video consultation or is a questionnaire enough?

Both models operate in Europe. Mobi Doctor uses video consultations at €43 with EU-licensed doctors; DoktorABC, Dokteronline, and Wellis are questionnaire-led. A video consultation allows a doctor to ask follow-up questions about contraindications that a fixed questionnaire cannot.

Why do prices vary so much between European countries?

Because licensing, pharmacy pricing, and reimbursement are national rather than EU-wide. The same medicine can carry meaningfully different prices in neighbouring markets, and availability differs because national prescribing rules differ.

Can I buy GLP-1 medication without a prescription in Europe?

No. GLP-1 weight loss medicines are prescription-only across the EU, as Mobi Doctor states explicitly. Any service offering them without a prescription is operating outside the law and should be avoided.

Bottom Line

European GLP-1 pricing runs from roughly €130 a month for a liraglutide generic to roughly €370 for Wegovy at maximum dose, with most semaglutide falling in the €250–€350 range.

Before comparing providers, check two things: whether your clinical indication qualifies you for reimbursement — which is usually the case for type 2 diabetes and usually not for weight management — and whether a national weight management pathway is available to you. Those two answers matter more than any price on this page.

If you are paying privately, consider separating the consultation from the dispensing so you can shop your prescription, and take the liraglutide option seriously if the weekly agents are out of reach.

US readers: CoreAge Rx offers all-in monthly pricing from $179–$399 including medication and provider messaging, with 12–24 hour approvals.

Medical disclaimer: Informational only, not medical or financial advice. GLP-1 receptor agonists are prescription medicines with real risks and contraindications. Availability, prescribing rules, pricing, and reimbursement differ substantially by country and change over time. Consult a qualified healthcare professional and verify pricing directly.

Sources: Provider published pricing pages as cited in the linked reviews; Mobi Doctor published European cost and eligibility guidance; European Medicines Agency product information; NICE tirzepatide guidance.

Date reviewed: August 2026